ADL
PFE icon

Asset Dedication LLC’s Pfizer PFE Stock Holding History

Asset Dedication LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$481K Sell
19,966
-985
-5% -$25.8K 0.03% 241
2026
Q1 		$588K Sell
20,951
-2,805
-12% -$74.7K 0.04% 209
2025
Q4 		$592K Sell
23,756
-259
-1% -$6.53K 0.04% 215
2025
Q3 		$612K Sell
24,015
-5,663
-19% -$140K 0.04% 212
2025
Q2 		$719K Buy
29,678
+7,786
+36% +$182K 0.05% 194
2025
Q1 		$555K Sell
21,892
-4,941
-18% -$129K 0.05% 198
2024
Q4 		$712K Buy
26,833
+13,896
+107% +$377K 0.06% 186
2024
Q3 		$374K Sell
12,937
-3,758
-23% -$110K 0.03% 262
2024
Q2 		$467K Buy
16,695
+669
+4% +$18.4K 0.03% 239
2024
Q1 		$443K Sell
16,026
-379
-2% -$10.5K 0.03% 230
2023
Q4 		$473K Sell
16,405
-15,126
-48% -$457K 0.04% 228
2023
Q3 		$1.04M Sell
31,531
-17,285
-35% -$611K 0.09% 169
2023
Q2 		$1.78M Buy
48,816
+3,237
+7% +$126K 0.15% 112
2023
Q1 		$1.87M Buy
45,579
+1,224
+3% +$52.9K 0.17% 109
2022
Q4 		$2.26M Sell
44,355
-1,132
-2% -$54.3K 0.23% 84
2022
Q3 		$1.99M Buy
+45,487
New +$2.21M 0.22% 92
2022
Q2 		– Sell
-45,017
Closed -$2.33M – 839
2022
Q1 		$2.33M Sell
45,017
-2,441
-5% -$127K 0.26% 87
2021
Q4 		$2.79M Buy
47,458
+4,173
+10% +$207K 0.34% 69
2021
Q3 		$1.86M Buy
43,285
+8,730
+25% +$387K 0.25% 92
2021
Q2 		$1.35M Buy
34,555
+10,400
+43% +$404K 0.2% 107
2021
Q1 		$869K Sell
24,155
-19,357
-44% -$687K 0.2% 116
2020
Q4 		$1.6M Sell
43,512
-4,134
-9% -$152K 0.32% 87
2020
Q3 		$1.66M Buy
47,646
+8,438
+22% +$296K 0.37% 76
2020
Q2 		$1.22M Buy
39,208
+2,900
+8% +$98.5K 0.33% 83
2020
Q1 		$1.13M Sell
36,308
-9,418
-21% -$321K 0.34% 83
2019
Q4 		$1.69M Buy
45,726
+4,453
+11% +$159K 0.48% 63
2019
Q3 		$1.41M Sell
41,273
-2,011
-5% -$73.1K 0.47% 61
2019
Q2 		$1.79M Buy
43,284
+1,799
+4% +$71.4K 0.58% 44
2019
Q1 		$1.68M Buy
41,485
+2,986
+8% +$120K 0.58% 46
2018
Q4 		$1.59M Buy
38,499
+4,641
+14% +$193K 0.65% 45
2018
Q3 		$1.42M Sell
33,858
-3,924
-10% -$151K 0.53% 60
2018
Q2 		$1.29M Sell
37,782
-1,150
-3% -$39.3K 0.44% 70
2018
Q1 		$1.31M Sell
38,932
-2,725
-7% -$93.7K 0.65% 48
2017
Q4 		$1.42M Buy
41,657
+9,711
+30% +$331K 0.57% 61
2017
Q3 		$1.07M Buy
31,946
+2,764
+9% +$88.8K 0.52% 59
2017
Q2 		$926K Buy
29,182
+415
+1% +$13.1K 0.47% 66
2017
Q1 		$924K Buy
28,767
+316
+1% +$9.96K 0.5% 64
2016
Q4 		$877K Buy
28,451
+3,309
+13% +$101K 0.51% 62
2016
Q3 		$805K Buy
25,142
+1,376
+6% +$46K 0.51% 60
2016
Q2 		$789K Buy
23,766
+481
+2% +$15.4K 0.55% 52
2016
Q1 		$655K Sell
23,285
-6,778
-23% -$194K 0.48% 66
2015
Q4 		$921K Buy
+30,063
New +$946K 0.6% 47

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Asset Dedication LLC's PFE Position: Q2 2026 in Review

Asset Dedication LLC reduced its Pfizer (PFE) stake by 4.7% in Q2 2026, selling an estimated $25.8K and leaving 19,966 shares worth $481K. The position accounts for 0.03% of the portfolio, ranked #241.

Asset Dedication LLC first reported a position in PFE in Q4 2015 and has held it in 42 quarters since. The position peaked at $2.79M in Q4 2021. 1,336 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Asset Dedication LLC held 19,966 shares of Pfizer worth $481K as of Q2 2026.
  • Asset Dedication LLC sold 985 Pfizer shares in Q2 2026, an estimated $25.8K.
  • Pfizer made up 0.03% of Asset Dedication LLC's portfolio in Q2 2026, its #241 holding.
  • Asset Dedication LLC first reported a position in Pfizer in Q4 2015 and has held it in 42 quarters since.
  • Asset Dedication LLC's Pfizer position peaked at $2.79M in Q4 2021.
  • 1,336 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.